Please note images are for illustration purposes and may differ from the product(s) you receive
Bonviva Tablet 150mg is indicated for the treatment of osteoporosis in women who have passed the menopause and are more at risk of bone fractures.
Bonviva Tablet 150mg contains the active ingredient ibandronic acid, which is a type of medicine called a bisphosphonate and it is used in the treatment of osteoporosis in menopausal women, as they are at a much higher risk of bone fractures. The ibandronic acid works by binding very tightly to the bone and prevents the loss of calcium. It also works to prevent the bone from breaking down to keep it strong and less likely to break or fracture.
Osteoporosis is a condition where bone strength is reduced and the chance of bone fractures could therefore be increased. The menopause greatly increases a woman’s chance of developing osteoporosis, as it causes a drop in the hormone estrogen, which is known for protecting the bones. The drop is estrogen at this stage of life then leads to bone loss, weakening of bones and a higher risk of fractures. Bone loss is particularly rapid for the first 10 years after the onset of the menopause and it can easily lead to the development of osteoporosis. There is therefore a well-established link between osteoporosis and the menopause, which is why this particular medicine is specifically tailored to strengthening bones in menopausal women.
Directions for taking Bonviva Tablet 150mg:
Caution before taking Bonviva Tablet 150mg:
Use with caution in:
Not to be used in:
Private and NHS prescription items are now fulfilled by our sister company Pharmacy2U. Learn more